Catalyst Pharmaceuticals, Inc. (CPRX)
22.71
+0.11
(+0.49%)
USD |
NASDAQ |
Jan 09, 16:00
22.90
+0.19
(+0.84%)
After-Hours: 18:19
Catalyst Pharmaceuticals Research and Development Expense (Quarterly): 2.657M for Sept. 30, 2025
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Collegium Pharmaceutical, Inc. | -- |
| ACADIA Pharmaceuticals, Inc. | 87.83M |
| Amicus Therapeutics, Inc. | 23.42M |
| Rigel Pharmaceuticals, Inc. | 7.353M |
| Krystal Biotech, Inc. | 13.18M |